Debiopharm

1 stories about Debiopharm
צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

AI cancer treatment startup Nucleai raises $6.5 million in series A round

07.07.20|Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment